Crypto Strategy Backfires: This Company Just Got Kicked Off the Nasdaq
TL;DR Windtree Therapeutics, a Pennsylvania-based biotech firm, has been delisted from the Nasdaq after its stock price collapsed below compliance levels, despite announcing a $700 million

